Oligonucleotide therapeutics represent a transformative treatment modality with demonstrated potential across metabolic disorders, CNS diseases, muscular dystrophies, and a broad...
Continue Reading
Inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn’s disease, is a chronic, immune-mediated disorder characterized by persistent inflammation...
Continue Reading
Introduction: Autoimmune skin diseases (AISDs) are a group of chronic inflammatory disorders characterized by the immune system mistakenly recognizing self-antigens...
Continue Reading
Cognitive dysfunction affects over 50 million individuals worldwide, with Alzheimer’s disease (AD) representing two-thirds of cases. Due to the complexity...
Continue Reading
Peptide drugs, composed of short chains of amino acids, represent a promising class of therapeutics with unique advantages over traditional...
Continue Reading
Targeted protein degradation (TPD) approaches, including molecular glue degraders (MGDs) and proteolysis targeting chimeras (PROTACs), can overcome traditional occupancy-based inhibitor...
Continue Reading
Strategies to stimulate dendritic cell (DC) activity, such as ex vivo generation and priming of DC vaccines, have been explored...
Continue Reading
KRAS mutations act as primary initiators of carcinogenesis in several major cancers and are present in approximately 20 – 25%...
Continue Reading
High-throughput screening (HTS) remains a foundational technology in early drug discovery, responsible for identifying approximately one-third of today’s clinical candidates....
Continue Reading
